ML
MiroBio utilizes the immune system's natural regulatory mechanisms to develop targeted therapies for autoimmune diseases. By enhancing immune tolerance, the company aims to reduce the incidence of adverse autoimmune responses in patients.
Updated 2 months ago
Funding
$97M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- MiroBio utilizes the immune system's natural regulatory mechanisms to develop targeted therapies for autoimmune diseases. By enhancing immune tolerance, the company aims to reduce the incidence of adverse autoimmune responses in patients.